Geron, Exeter Affiliates Merge to Create Livestock Cloning Shop
By GenomeWeb,
GenomeWeb
| 08. 12. 2008
NEW YORK (GenomeWeb News) - Geron and Exeter Life Sciences said today that Start Licensing, a joint venture between the two firms, and ViaGen, a subsidiary of Exeter, have merged to form a new entity that will focus on animal cloning.
Start manages and licenses a portfolio of intellectual property rights related to animal reproductive technologies, including nuclear transfer cloning technology that was developed at the Roslin Foundation to clone Dolly the sheep. ViaGen is an animal genomics and livestock cloning firm.
Geron and Exeter said that the merger of the firms combines the "full breadth" of Start's nuclear transfer cloning IP with ViaGen's in-house breeding services and expertise in advanced reproductive technologies, including cloning, "to provide a one-stop licensing and operating company" for animal cloning.
"We believe it makes sound business sense to join a patent estate for nuclear transfer that has been tested and is recognized as dominant with a leading operating company in the field," said David Greenwood, Geron's executive vice president and CFO, in a statement.
Jonathan Thatcher, Exeter Life Science's CEO, said that the combined...
Related Articles
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By Steve Rose, The Guardian | 01.28.2026
Ed Zitron, EZPR.com; Experience Summit stage;
Web Summit 2024 via Wikipedia Commons licensed under CC by 2.0
If some time in an entirely possible future they come to make a movie about “how the AI bubble burst”, Ed Zitron will...
By Phil Galewitz, NPR | 01.20.2026
Serenity Cole enjoyed Christmas last month relaxing with her family near her St. Louis home, making crafts and visiting friends.
It was a contrast to how Cole, 18, spent part of the 2024 holiday season. She was in the hospital...
By Shobita Parthasarathya, Science | 01.22.2026
These are extraordinarily challenging times for university researchers across the United States. After decades of government largess based on the idea that a large and well-financed research ecosystem will produce social and economic progress, there have been huge cuts in...
